WELCOME TO

Specialist Communications for Life Sciences
Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value and generate interest from commercial leads, investors and partners.

Our
Services
Focused on supporting life science companies to raise their profile, build corporate value, and generate interest, the services we provide include:
PR & Media
- Press releases
- Article writing and placement
- Media interviews
- Messaging
- Copy writing
- Social media
- Media training
- Events
Marketing
- Conference, event and trade show support
- Marketing literature
- Market research
- Campaign development
- Advertising
- Sponsorship
- Product launches
Design & Branding
- Website design and development
- Print collateral development
- Identity and logo creation
- Brand strategy
- Presentation development
- Video production
Investor Relations
- Business plan development
- Presentation development
- PR targeting the life science trade press read by investors

The
Team
An experienced senior team of specialists in life science communications, with expertise gained in-house and agency side, offering the flexibility to support both early-stage companies and large multinationals.
EVENTS
-
Jefferies – Global Healthcare Conference in London
-
Cancer Research Horizons Innovation Summit
-
Oxford-Cambridge Innovation Showcase 2025
-
SLAS-ELRIG 2025 Meet-up: AI in Automation
Scottish Brain Sciences opens new Alzheimer’s clinical research centre at ONE BioHub
Aberdeen clinical research centre widens access to clinical trials across Scotland, advancing early Alzheimer’s research ONE BioHub provides Scottish Brain Sciences with infrastructure and integrated support to scale operations and [...]
Mosaic Therapeutics appoints Dr Stephen Shuttleworth as Chief Scientific Officer
Venture Partner at Samsara BioCapital, and former CSO and COO of Karus Therapeutics, brings deep scientific and industry experience to Mosaic’s Executive Leadership team Stephen will lead the Company’s scientific [...]
Mursla Bio collaborates with a leading global pharma company to advance biomarker-guided precision medicine in MASH
Mursla Bio’s AI Precision Medicine Platform to inform drug development and patient stratification in metabolic liver disease Cambridge, UK, and Boston MA, USA, 13 November 2025: Mursla Bio, a leader [...]




















